TG Therapeutics Strikes Global Alliance To Develop Novel BET Inhibitors For Hematological Malignancies Treatment
May 27, 2016 at 09:00 AM EDT
TG Therapeutics, Inc. (NASDAQ: TGTX), revealed Friday that as part of a broader agreement with Jubilant Biosys, an Indian biotech ...